Early after stroke, STAT6 is reported to mediate effective efferocytosis and anti-inflammatory responses of microglia and STAT6/Arg1 signaling is proposed to be a viable therapeutic target to regulate microglia functions and promote long-term favorable outcomes during brain injury (Cai et al., 2019). Here, STAT6 is linked to stroke disorder.